Stock SLS SELLAS LIFE SCIENCES GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Real-time Estimate Cboe BZX
Other stock markets
 13:12:17 2024-06-03 EDT 		5-day change 1st Jan Change
1.43 USD +1.42% Intraday chart for SELLAS Life Sciences Group, Inc. +3.99% +35.38%
05-19 Certain Common Stock of SELLAS Life Sciences Group, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. CI
05-14 SELLAS Life Sciences Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SELLAS LIFE SCIENCES GROUP, INC. Stock SELLAS Life Sciences Group, Inc.
 81.43M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Charts SELLAS Life Sciences Group, Inc.
  5. Sector Chart